DEFRIJET FCT 180 Tablet 10’s is an iron-chelating agent used to remove excess iron from the body (also known as iron overload). It contains an active ingredient called Deferasirox which traps and removes the excess iron from the body which is excreted mainly in the stools.
DEFRIJET FCT 180 Tablet 10’s benefits people with iron overload caused due to frequent blood transfusions in conditions like beta-thalassemia major, sickle cell disease, and myelodysplastic syndromes. It is also prescribed for patients with non-transfusion-dependent thalassemia who develop iron overload due to increased dietary iron absorption.
Take Defrijet FCT 180 once daily at the same time each day, preferably on an empty stomach or with a light meal. The dosage is determined by the doctor based on iron levels and treatment goals. Regular monitoring of iron levels, kidney function, and liver function is essential throughout treatment.
Common side effects of Defrijet FCT 180 include nausea, diarrhea, stomach pain, vomiting, and skin rashes. In some cases, it may cause serious side effects such as kidney or liver problems, gastrointestinal bleeding, or hearing and vision disturbances. Patients with existing kidney or liver conditions should use this medicine cautiously under medical supervision. Avoid alcohol and grapefruit juice, as they may affect drug absorption.
Defrijet FCT 180 Tablets should be avoided in pregnancy and breastfeeding unless prescribed by a doctor after assessing the risks and benefits. Women should discuss pregnancy planning and breastfeeding options with their healthcare provider before starting or continuing treatment.
Defrijet FCT 180 is approved for usage in children above 2 years (with transfusions), adolescents, and elderly patients, but dose adjustments and close monitoring are necessary, especially in the elderly due to increased side effect risks.
No content available
